Transaction DateRecipientSharesTypePriceValue
21st August 2020Holding, S.A. Biodyne75,000Open or private sale$0.38$28,500.00
20th August 2020Holding, S.A. Biodyne75,000Open or private sale$0.27$20,250.00
19th August 2020Holding, S.A. Biodyne50,000Open or private sale$0.30$15,000.00
18th August 2020Holding, S.A. Biodyne50,000Open or private sale$0.34$17,000.00
14th August 2020Holding, S.A. Biodyne50,000Open or private sale$0.31$15,500.00
3rd August 2020Holding, S.A. Biodyne70,000Open or private sale$0.32$22,400.00
31st July 2020Holding, S.A. Biodyne5,000Open or private sale$0.34$1,700.00
30th July 2020Holding, S.A. Biodyne25,000Open or private sale$0.32$8,000.00
21st July 2020Holding, S.A. Biodyne50,000Open or private sale$0.45$22,500.00
20th July 2020Holding, S.A. Biodyne150,000Open or private sale$0.43$64,500.00
Hancock Jaffe Laboratories
Hancock Jaffe Laboratories logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


Hancock Jaffe Laboratories, Inc. is a development stage medical device company. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve.


Ticker: HJLI
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1661053
Employees: 12
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals